NCT00377715View on ClinicalTrials.gov

Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

183

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2006

Conditions

Alzheimer's Disease

Interventions

DRUG

Dimebon

DRUG

Placebo

Trial Locations (1)

Unknown

Mental Health Research Center of Russian Academy of Medical Sciences, Moscow

Sponsors

Lead Sponsor

Medivation, Inc.

All Listed Sponsors

lead

Medivation, Inc.

INDUSTRY

NCT00377715 - Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter